Related Experiment Video
Updated: Aug 12, 2026

Preparation of Primary Myogenic Precursor Cell/Myoblast Cultures from Basal Vertebrate Lineages
Published on: April 30, 2014
Inhibition of myogenesis by trifluoperazine and compound 48/80
Abstract:
When trifluoperazine (TFP), a calmodulin antagonist, was given to chick or rat myoblasts in cultures, formation of multinucleated myotubes was inhibited. The inhibition of cell fusion by TFP in rat cultures prevents the normal increase in the amount of acetylcholine receptors (AChR) and creatine kinase (CK), while the levels of these proteins in chick muscle cultures are hardly affected. Another calmodulin antagonist, compound 48/80, inhibits fusion at doses that correspond closely to its antagonistic effects on calmodulin. Thus, our results suggest a possible role for calmodulin in the regulation of myoblast fusion, but not on the appearance of muscle proteins.
Insights
Trifluoperazine, a calmodulin antagonist, inhibited myoblast fusion in chick and rat cultures. This drug affected muscle protein levels in rats but not chicks, suggesting calmodulin regulates myoblast fusion, not muscle protein synthesis.
Area of Science:
- Cell Biology
- Developmental Biology
- Neuroscience
Background:
- Myoblast fusion is crucial for skeletal muscle development, forming multinucleated myotubes.
- Calmodulin is a calcium-binding protein involved in various cellular processes.
- The precise regulatory mechanisms of myoblast fusion are not fully understood.
Purpose of the Study:
- To investigate the role of calmodulin in myoblast fusion.
- To determine if calmodulin antagonists affect muscle-specific protein expression during myogenesis.
Main Methods:
- Primary myoblasts from chick and rat embryos were cultured.
- Cells were treated with calmodulin antagonists trifluoperazine (TFP) and compound 48/80.
- Inhibition of myotube formation and levels of acetylcholine receptors (AChR) and creatine kinase (CK) were assessed.
Main Results:
- Trifluoperazine significantly inhibited multinucleated myotube formation in both chick and rat myoblasts.
- In rat myoblasts, TFP treatment prevented the normal increase in AChR and CK levels.
- Chick myoblasts showed minimal changes in AChR and CK levels despite inhibited fusion.
- Compound 48/80 also inhibited myoblast fusion, correlating with its calmodulin antagonistic activity.
Conclusions:
- Calmodulin plays a regulatory role in the process of myoblast fusion.
- Calmodulin's role in myoblast fusion appears to be species-specific, affecting protein level regulation differently in rats and chicks.
- Calmodulin does not seem to regulate the appearance of muscle-specific proteins like AChR and CK.
More Related Videos
09:20Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
10:24A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Classification of Skeletal Muscle Relaxants
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Anthelminthic Agents